Moderna vaccine introduced for teen vaccinations

Latvia has started vaccination of 12-17 year old minors against Covid-19 with Moderna vaccine, the National Health Service reported July 30

So far, only Pfizer/BioNTech vaccine has been used for vaccination of teenagers.

On July 20, the State Agency of Medicines reported that the European Medicines Agency has approved use of Moderna vaccines for 12-17 year old children. The vaccine has been studied on 3,732 teenagers.

Until July 31, 16 percent of teenagers aged 12-15, and 32 percent of teenagers aged 16-17 have received one vaccine dose.

Seen a mistake?

Select text and press Ctrl+Enter to send a suggested correction to the editor

Select text and press Report a mistake to send a suggested correction to the editor

Most important

Please be aware that the LSM portal uses cookies. By continuing to use this site, you agree that we may store and use cookies on your device. Find out more

Accept and continue